A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs

Start
Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.
Previous Story

More Mail Ballots Are Arriving Late This Year, and They’re Getting Tossed

Next Story

Why We’re Not Hanging Up on Phone Polling